Mayne Pharma Group (AU:MYX) has released an update.
Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Mayne Pharma Group is set to host an interactive investor education webinar focused on its US Women’s Health and Dermatology segments. These sectors have shown significant revenue growth, with Women’s Health up 131% and Dermatology up 207% in FY24 compared to the previous year. The webinar will feature insights from key executives and include an interactive Q&A session, offering a valuable opportunity for investors to engage with the company.
For further insights into AU:MYX stock, check out TipRanks’ Stock Analysis page.
